Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Clinical studies demonstrate substantial HbA1c reductions (up to ?2.4%) and body weight losses exceeding 20% with high-dose regimens in people with obesity and type 2 diabetes 1,2
The pill, which shares the same active ingredient as Wegovy, is expected to be available in early 2026
Ask whether a slower dose escalation or a lower maintenance dose might reduce sexual side effects while preserving weight loss benefits
That meant drug compounderspharmacists, facilities, and others who mix ingredients to create medications in shortagesmust stop producing copies of semaglutide, the active ingredient in Novos drug
US$ 22.98
US$ 22.73
US$ 26.88
